BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7282112)

  • 21. Myasthenia gravis and D-penicillamine.
    Dawkins RL; Garlepp MJ; McDonald BL; Williamson J; Zilko PJ; Carrano J
    J Rheumatol Suppl; 1981; 7():169-74. PubMed ID: 7014873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 24. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP; Lee YS; Kornfeld P; Fries JF
    J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report.
    Naidoo PD
    S Afr Med J; 1981 Sep; 60(12):478. PubMed ID: 7280897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)].
    Suzuki H; Imai H; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):163-70. PubMed ID: 7414431
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myasthenia caused by D-penicillamine in rheumatoid arthritis].
    Héraud A; Dromer C; Fatout E; Fournié B; Fournié A
    Rev Rhum Ed Fr; 1994 Jan; 61(1):59-60. PubMed ID: 8000404
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillamine-induced myasthenia gravis.
    Myers A; Songcharoen S; Harisdangkul V
    J Miss State Med Assoc; 1984 Feb; 25(2):27-8. PubMed ID: 6699910
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myasthenia gravis induced by D-penicillamine].
    Berstad J
    Tidsskr Nor Laegeforen; 1983 Aug; 103(23):1646-7. PubMed ID: 6636079
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies.
    Fawcett PR; McLachlan SM; Nicholson LV; Argov Z; Mastaglia FL
    Muscle Nerve; 1982 Apr; 5(4):328-34. PubMed ID: 7099199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [D-penicillamine-induced myasthenia gravis].
    Murros K; Möttönen T
    Duodecim; 1984; 100(5):292-4. PubMed ID: 6714116
    [No Abstract]   [Full Text] [Related]  

  • 37. Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies.
    Masters CL; Dawkins RL; Zilko PJ; Simpson JA; Leedman RJ
    Am J Med; 1977 Nov; 63(5):689-94. PubMed ID: 930944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myasthenic syndrome during treatment with D penicillamine. A recent case].
    Verret JM; Lignac N; Kahn MF
    Ann Med Interne (Paris); 1977; 128(6-7):557-60. PubMed ID: 921113
    [No Abstract]   [Full Text] [Related]  

  • 39. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 40. [3 cases of myasthenic syndrome induced by D-penicillamine].
    Derman H; Théron HP
    Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1235-6, 1241-3. PubMed ID: 3451832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.